BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33036571)

  • 1. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
    Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
    Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
    N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatic heart disease in Uganda: predictors of morbidity and mortality one year after presentation.
    Okello E; Longenecker CT; Beaton A; Kamya MR; Lwabi P
    BMC Cardiovasc Disord; 2017 Jan; 17(1):20. PubMed ID: 28061759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence.
    Engelman D; Ah Kee M; Mataika RL; Kado JH; Colquhoun SM; Tulloch J; Steer AC
    Trans R Soc Trop Med Hyg; 2017 Apr; 111(4):154-162. PubMed ID: 28673022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.
    Beaton A; Aliku T; Dewyer A; Jacobs M; Jiang J; Longenecker CT; Lubega S; McCarter R; Mirabel M; Mirembe G; Namuyonga J; Okello E; Scheel A; Tenywa E; Sable C; Lwabi P
    Circulation; 2017 Dec; 136(23):2233-2244. PubMed ID: 28972003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiography screening for rheumatic heart disease in Ugandan schoolchildren.
    Beaton A; Okello E; Lwabi P; Mondo C; McCarter R; Sable C
    Circulation; 2012 Jun; 125(25):3127-32. PubMed ID: 22626741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to secondary antibiotic prophylaxis for patients with rheumatic heart disease diagnosed through screening in Fiji.
    Engelman D; Mataika RL; Kado JH; Ah Kee M; Donath S; Parks T; Steer AC
    Trop Med Int Health; 2016 Dec; 21(12):1583-1591. PubMed ID: 27730711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic Heart Disease Treatment Cascade in Uganda.
    Longenecker CT; Morris SR; Aliku TO; Beaton A; Costa MA; Kamya MR; Kityo C; Lwabi P; Mirembe G; Nampijja D; Rwebembera J; Sable C; Salata RA; Scheel A; Simon DI; Ssinabulya I; Okello E
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
    Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.
    Zachariah JP; Samnaliev M
    J Med Econ; 2015 Jun; 18(6):410-9. PubMed ID: 25629653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic heart disease in Timor-Leste school students: an echocardiography-based prevalence study.
    Davis K; Remenyi B; Draper AD; Dos Santos J; Bayley N; Paratz E; Reeves B; Appelbe A; Cochrane A; Johnson TD; Korte LM; Do Rosario IM; Da Silva Almeida IT; Roberts KV; Carapetis JR; Francis JR
    Med J Aust; 2018 Apr; 208(7):303-307. PubMed ID: 29642817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivations of women in Uganda living with rheumatic heart disease: A mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception.
    Chang AY; Nabbaale J; Nalubwama H; Okello E; Ssinabulya I; Longenecker CT; Webel AR
    PLoS One; 2018; 13(3):e0194030. PubMed ID: 29590159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperendemic rheumatic heart disease in a remote Australian town identified by echocardiographic screening.
    Francis JR; Fairhurst H; Hardefeldt H; Brown S; Ryan C; Brown K; Smith G; Baartz R; Horton A; Whalley G; Marangou J; Kaethner A; Draper AD; James CL; Mitchell AG; Yan J; Ralph A; Remenyi B
    Med J Aust; 2020 Aug; 213(3):118-123. PubMed ID: 32632952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health system and patient-level factors serving as facilitators and barriers to rheumatic heart disease care in Sudan.
    Edwards JG; Barry M; Essam D; Elsayed M; Abdulkarim M; Elhossein BMA; Mohammed ZHA; Elnogomi A; Elfaki ASE; Elsayed A; Chang AY
    Glob Health Res Policy; 2021 Oct; 6(1):35. PubMed ID: 34598719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.
    Beaton A; Okello E; Rwebembera J; Grobler A; Engelman D; Alepere J; Canales L; Carapetis J; DeWyer A; Lwabi P; Mirabel M; Mocumbi AO; Murali M; Nakitto M; Ndagire E; Nunes MCP; Omara IO; Sarnacki R; Scheel A; Wilson N; Zimmerman M; Zühlke L; Karthikeyan G; Sable CA; Steer AC
    N Engl J Med; 2022 Jan; 386(3):230-240. PubMed ID: 34767321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and Care Quality Metrics for Women of Reproductive Age Living With Rheumatic Heart Disease in Uganda.
    Chang AY; Nabbaale J; Okello E; Ssinabulya I; Barry M; Beaton AZ; Webel AR; Longenecker CT
    J Am Heart Assoc; 2020 Apr; 9(8):e015562. PubMed ID: 32295465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.